jatrorrhizine has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, X; Gui, Z; Li, X; Ye, X | 1 |
| Cheang, WS; Ruan, CC; Vong, CT; Wang, Y; Xu, B; Zhou, Y; Zhu, Y | 1 |
2 other study(ies) available for jatrorrhizine and Diabetes Mellitus
| Article | Year |
|---|---|
Jatrorrhizine ameliorates Schwann cell myelination via inhibiting HDAC3 ability to recruit Atxn2l for regulating the NRG1-ErbB2-PI3K-AKT pathway in diabetic peripheral neuropathy mice.
Topics: Animals; Diabetes Mellitus; Diabetic Neuropathies; Histone Deacetylases; Mice; Neuregulin-1; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Schwann Cells; Sciatic Nerve | 2023 |
Jatrorrhizine Improves Endothelial Function in Diabetes and Obesity through Suppression of Endoplasmic Reticulum Stress.
Topics: Acetylcholine; Alanine Transaminase; Animals; Aspartate Aminotransferases; Diabetes Mellitus; Drugs, Chinese Herbal; Endoplasmic Reticulum Stress; Endothelium, Vascular; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hypoglycemic Agents; Lipids; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Proto-Oncogene Proteins c-akt; Tunicamycin | 2022 |